Hormone therapy plus chemo before surgery for early breast cancer
Part of Cancer clinical trials.
This trial tests a new approach: combining hormone therapy with chemotherapy before surgery for early-stage breast cancer. It may help shrink the tumor and improve chances of successful treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- Your breast cancer is ER-positive and HER2-negative, with a high Ki67 score (a measure of how fast the cancer cells are dividing).
- Your cancer is stage I, II, or III (it has not spread to distant parts of the body).
- You have not had previous chemotherapy or hormone therapy for breast cancer.
- You are generally healthy enough to undergo treatment (no serious heart, liver, or kidney problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares hormone-based treatment versus chemotherapy given before surgery in people who are premenopausal and have hormone-receptor positive, HER2-negative breast cancer. It looks to see which approach works better to control the cancer before the breast operation.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
This trial tests combining hormone therapy with chemotherapy and targeted therapy before surgery for a type of breast cancer that is both hormone-receptor-positive (HR+) and HER2-positive. The goal is to see if this combination works better than standard treatment.
This study tests different treatment plans given before surgery for early breast cancer that is both hormone receptor-positive and HER2-positive. The goal is to see which treatment is more effective and to tailor it to each patient.
This trial tests giving chemotherapy before surgery to shrink breast tumors, which may make surgery easier or allow breast-conserving options. It is for adults with invasive breast cancer that has not spread to distant organs.
This trial tests a combination of chemotherapy, immunotherapy, and targeted radiation given before surgery for a certain type of breast cancer. The goal is to see if this approach can shrink tumors and improve outcomes.
Hear when a new Invasive Breast Cancer (Stage I-III) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.